The Journal of Practical Medicine ›› 2025, Vol. 41 ›› Issue (7): 1056-1061.doi: 10.3969/j.issn.1006-5725.2025.07.019
• Medical Examination and Clinical Diagnosis • Previous Articles
Fuxia ZHENG1,Lijun MIAO2,Fengxiang HUANG2,Shifu HUANG3,Zengyan GAO4,Ruixia ZHANG5,Yong MENG1
Received:
2025-01-20
Online:
2025-04-10
Published:
2025-04-23
CLC Number:
Fuxia ZHENG,Lijun MIAO,Fengxiang HUANG,Shifu HUANG,Zengyan GAO,Ruixia ZHANG,Yong MENG. The correlation between the levels of APC, TXB2, and sB7⁃H3 in peripheral blood of elderly patients with pneumonia and the severity and prognosis of the disease[J]. The Journal of Practical Medicine, 2025, 41(7): 1056-1061.
Tab.1
Comparison of peripheral blood APC, TXB2, and sB7-H3 levels between the study group and the control group x ± s"
组别 | 例数 | APC/(ng/mL) | TXB2/(ng/L) | sB7-H3/(pg/mL) |
---|---|---|---|---|
研究组 | 100 | 286.72 ± 72.13 | 366.49 ± 114.32 | 3 815.77 ± 836.19 |
对照组 | 100 | 445.58 ± 80.37 | 202.65 ± 52.12 | 2 560.28 ± 352.74 |
t值 | 14.711 | 13.040 | 13.834 | |
P值 | < 0.001 | < 0.001 | < 0.001 |
Tab.2
Comparison of peripheral blood APC, TXB2, and sB7-H3 levels in patients with different degrees of disease in the study group"
组别 | 例数 | APC(ng/mL) | TXB2(ng/L) | sB7-H3(pg/mL) |
---|---|---|---|---|
轻度患者 | 33 | 345.23 ± 67.26 | 307.43 ± 58.19 | 3 276.09 ± 571.23 |
中度患者 | 39 | 281.61 ± 62.59? | 365.92 ± 63.37? | 3 807.44 ± 602.18? |
重度患者 | 28 | 224.88 ± 57.80?# | 436.89 ± 80.05?# | 4 463.42 ± 632.57?# |
F值 | 27.934 | 28.375 | 29.576 | |
P值 | < 0.001 | < 0.001 | < 0.001 |
Tab.3
Clinical data, peripheral blood APC, TXB2, sB7-H3 levels of patients with different prognoses in the study group"
资料 | 预后不良组(n = 21) | 预后良好组(n = 79) | t/χ 2 值 | P值 |
---|---|---|---|---|
性别/[例(%)] | 0.093 | 0.761 | ||
男 | 13(61.90) | 46(58.23) | ||
女 | 8(38.10) | 33(41.77) | ||
年龄/岁 | 67.82 ± 2.54 | 67.59 ± 2.30 | 0.399 | 0.691 |
BMI/(kg/m2) | 22.06 ± 1.69 | 22.18 ± 1.74 | 0.283 | 0.778 |
吸烟史/[例(%)] | 9(42.86) | 30(37.97) | 0.166 | 0.684 |
高血压/[例(%)] | 7(33.33) | 23(29.11) | 0.141 | 0.708 |
糖尿病/[例(%)] | 7(33.33) | 10(12.66) | 5.026 | 0.025 |
肺炎类型/[例(%)] | 0.002 | 0.964 | ||
细菌性肺炎 | 17(80.95) | 66(83.54) | ||
病毒性肺炎 | 4(19.05) | 13(16.46) | ||
病情程度/[例(%)] | 5.267 | < 0.001 | ||
低危 | 1(4.76) | 32(40.51) | ||
中危 | 2(9.52) | 37(46.84) | ||
高危 | 18(85.71) | 10(12.66) | ||
APACHEⅡ评分/分 | 20.65 ± 2.13 | 18.40 ± 1.75 | 4.997 | < 0.001 |
外周血指标 | ||||
APC/(ng/mL) | 233.63 ± 58.44 | 300.83 ± 68.39 | 4.117 | < 0.001 |
TXB2/(ng/L) | 435.15 ± 84.20 | 348.24 ± 106.37 | 3.463 | 0.001 |
sB7-H3/(pg/mL) | 4 457.92 ± 769.36 | 3 645.07 ± 812.75 | 4.118 | < 0.001 |
1 |
LUO A H, LIU Y. The effect of low-molecular-weight heparin combined with amikacin on the coagulation function and bacterial clearance in the treatment of patients with severe senile pneumonia[J]. Pak J Med Sci,2023,39(1):172-176. doi:10.12669/pjms.39.1.6627
doi: 10.12669/pjms.39.1.6627 |
2 | 杨幸乐,夏婷婷,左春磊,等. 微生物学快速现场评价在重症肺炎中的应用价值[J]. 实用医学杂志,2023,39(22):2964-2968. |
3 |
MUHAMMAD W, ZHAI Z L, WANG S Q,et al. Inflammation-modulating nanoparticles for pneumonia therapy[J]. Wiley Interdiscip Rev Nanomed Nanobiotechnol,2022,14(2):e1763. doi:10.1002/wnan.1763
doi: 10.1002/wnan.1763 |
4 |
CONWAY E M, MACKMAN N, WARREN R Q,et al. Understanding COVID-19-associated coagulopathy[J]. Nat Rev Immunol,2022,22(10):639-649. doi:10.1038/s41577-022-00762-9
doi: 10.1038/s41577-022-00762-9 |
5 | 付君静,李闯,陈胜阳. 老年重症肺炎患者血清4-HNE、APC、sCD163预测预后不良的价值[J]. 海南医学,2024,35(11):1633-1638. |
6 | CHEN L C, TSENG H M, KUO M L,et al. Levels of 15-HETE and TXB2 in exhaled breath condensates as markers for diagnosis of childhood asthma and its therapeutic outcome[J]. Pediatr Allergy Immunol,2021,32(8):1673-1680. |
7 |
GENOVA C, TASSO R, ROSA A,et al. Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors[J]. Cells,2023,12(6):832. doi:10.3390/cells12060832
doi: 10.3390/cells12060832 |
8 | 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 成人社区获得性肺炎基层诊疗指南(2018年)[J]. 中华全科医师杂志,2019,18(2):117-126. |
9 | CARLOS P, GOMES R, COELHO J,et al. CURB-65 and Long-Term Mortality of Community-Acquired Pneumonia: A Retrospective Study on Hospitalized Patients[J]. Cureus,2023,15(3):e36052. |
10 |
SILVA B R D S, SIDARTA-OLIVEIRA D, MORARI J,et al. Protein C Pretreatment Protects Endothelial Cells from SARS-CoV-2-Induced Activation[J]. Viruses,2024,16(7):1049. doi:10.3390/v16071049
doi: 10.3390/v16071049 |
11 | 李汉冬,孙立宇,韩永梅,等. 血清FKN、APC与老年社区获得性肺炎患者病情和预后不良的关系[J]. 现代生物医学进展,2024,24(2):333-337. |
12 |
OI I, ITO I, TANABE N,et al. Protein C activity as a potential prognostic factor for nursing home-acquired pneumonia[J]. PLoS One,2022,7(10):e0274685. doi:10.1371/journal.pone.0274685
doi: 10.1371/journal.pone.0274685 |
13 |
KHOSHNEGAH Z, SIYADAT P, ROSTAMI M,et al. Protein C and S activities in COVID-19: A systematic review and meta-analysis[J]. J Thromb Thrombolysis,2024,57(6):1018-1030. doi:10.1007/s11239-024-02971-6
doi: 10.1007/s11239-024-02971-6 |
14 |
SILVA B R S, JARA C P, SIDARTA-OLIVEIRA D,et al. Downregulation of the Protein C Signaling System Is Associated with COVID-19 Hypercoagulability-A Single-Cell Transcriptomics Analysis[J]. Viruses,2022,14(12):2753. doi:10.3390/v14122753
doi: 10.3390/v14122753 |
15 |
FURUKAWA T, AKAIKE K, IYAMA S,et al. Interstitial Lung Disease in Adulthood Associated with Surfactant Protein C Gene Mutation in a Patient with a History of Lipoid Pneumonia in Infancy[J]. Intern Med,2023,62(17):2521-2525. doi:10.2169/internalmedicine.0980-22
doi: 10.2169/internalmedicine.0980-22 |
16 |
RADE J J, BARTON B A, VASAN R S,et al. Association of Thromboxane Generation With Survival in Aspirin Users and Nonusers[J]. J Am Coll Cardiol,2022,80(3):233-250. doi:10.1016/j.jacc.2022.04.034
doi: 10.1016/j.jacc.2022.04.034 |
17 | 梁利红. 血清及肺泡灌洗液γ干扰素,血栓素和可溶性B7-H3在难治性肺炎支原体肺炎中的鉴别诊断价值分析[J]. 安徽医药,2020,24(10):2054-2058. |
18 |
LIU X, CHEN R H, LI B H,et al. Oxidative stress indexes as biomarkers of the severity in COVID-19 patients[J]. Int J Med Sci,2024,21(15):3034-3045. doi:10.7150/ijms.102879
doi: 10.7150/ijms.102879 |
19 |
GARSHICK M S, TAWIL M, BARRETT T J,et al. Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis via COX-1[J]. Arterioscler Thromb Vasc Biol,2020,40(5):1340-1351. doi:10.1161/atvbaha.119.314008
doi: 10.1161/atvbaha.119.314008 |
20 | 吴会芳,张景丽,刘晓娟,等. 支气管镜治疗儿童肺炎支原体肺炎临床观察及黏液栓形成的危险因素[J]. 国际呼吸杂志,2021,41(12):908-913. |
21 | 刘庆,卢蓉,赵力芳. 支原体肺炎患儿血栓素B2嗜酸性细胞阳离子蛋白T-IgE水平与支气管镜下气道改变的关系分析[J].山西医药杂志,2021,50(7):1128-1131. |
22 | 郭静,刘泮力. 肿瘤坏死因子-α、内皮素-1、免疫球蛋白E和血栓素B2水平与肺炎支原体感染老年哮喘患者病情严重程度的关系[J]. 陕西医学杂志,2022,51(7):863-865,869. |
23 |
PICARDA E, GALBO P M JR, ZONG H H,et al. The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development[J]. Sci Adv,2022,8(17):eabm7012. doi:10.1126/sciadv.abm7012
doi: 10.1126/sciadv.abm7012 |
24 | 臧瑗,刘亚丽,张中. 血浆可溶性B7-H3预测老年肺炎支原体肺炎严重程度的价值[J]. 实用老年医学,2020,34(7):670-673. |
25 |
WU P, WANG J. Changes and Significance of Serum sB7-H3 and Cytokines in Children with Mycoplasma pneumonae Pneumonia[J]. J Coll Physicians Surg Pak,2020,30(3):268-271. doi:10.29271/jcpsp.2020.03.268
doi: 10.29271/jcpsp.2020.03.268 |
26 |
GU W J, LI G, ZHANG W L,et al. MiR-29b regulates Th2 cell differentiation in asthma by targeting inducible B7-H3 and STAT3[J]. Clin Transl Allergy,2022,12(1):e12114. doi:10.1002/clt2.12114
doi: 10.1002/clt2.12114 |
27 |
FENG Y, LEE J, YANG L P,et al. Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability[J]. Cell Rep,2023,42(12):113503. doi:10.1016/j.celrep.2023.113503
doi: 10.1016/j.celrep.2023.113503 |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||